ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0741

Constitutive Inhibitor Kappa B (IκB) Kinase 2 (IKK2) Activation Induces an Inflammatory State in Fibroblast-Like Synoviocytes

Sergio Ramirez-Perez1, Umesh Gangishetti1, Kyle Jones1 and Pallavi Bhattaram2, 1Department of Orthopaedics, Department of Cell Biology, Emory University School of Medicine, Atlanta, GA, 2EMORY UNIVERSITY, Atlanta, GA

Meeting: ACR Convergence 2020

Keywords: Experimental Arthritis, Fibroblasts, Synovial, rheumatoid arthritis, signal transduction, Synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 7, 2020

Title: RA – Animal Models Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Fibroblast-like synoviocytes (FLS) are key players involved in the production of inflammatory mediators that trigger joint tissue damage in inflammatory arthritis (IA). The most important mechanism proposed for FLS activation is the NF-κB-dependent signalling pathway. Inhibitor kappa B (IκB) kinase 2 (IKK2) plays a critical role in the activation of NF-κB, resulting in transcription of several inflammation-associated genes. The aim of this research was the characterization of a constitutive IKK2 activation (IKK2ca) in FLS as a strategy to study tissue-specific inflammation in the joint.

Methods: In order to acquire new information regarding pathological pathways underlying IA, we develop an R26StopFLikk2ca-Prg4CreERT2 mouse model, which expresses a constitutive active form of IKK2 restricted to Prg4-expressing cells in the joints. Cre-recombinase activation was induced by tamoxifen (TMX) intraperitoneal injection to 2-month old mice. Samples were collected after 4 weeks of TMX injection. Isolation of FLS was performed and NF-κB signalling pathway activation was analyzed by RT-qPCR and western blot. Additionally, flow cytometry was carried out to identify IKK2ca FLS population (Prg4 red cells). FLS at passages 2 to 4 were used for all experiments. R26-tdTomato-Prg4CreERT2 and TNFtg/0rtTAtg/0 FLS were taken as Wild type (WT) for RT-qPCR, western blot, and FACS analysis.

Results: Preliminary results showed high expression of IKK2 in IKK2ca FLS compared with WT FLS, as well as decreased expression of IκBα in the cytoplasm because of IKK2 constitutive activation. However, we did not observe differences in RelA nuclear expression between IKK2ca and WT FLS. In addition, we identify higher expression of Il1b, Il6, Nanog, and Sox2 genes in IKK2ca than in WT FLS, which is consistent with the inflammatory state of IKK2ca FLS established in IA. Regarding FACS results, we identified a specific synovial sub-lining inflammatory population of IKK2ca-Prg4 CD14– Thy1+ tdTomato+ FLS, which has reported as key player in IA.

Conclusion: Constitutive IKK2 activation in FLS induces an inflammatory phenotype characterized by increased expression of proinflammatory mediators, and represents an interesting strategy to study tissue-specific inflammation in the joint.


Disclosure: S. Ramirez-Perez, None; U. Gangishetti, None; K. Jones, None; P. Bhattaram, None.

To cite this abstract in AMA style:

Ramirez-Perez S, Gangishetti U, Jones K, Bhattaram P. Constitutive Inhibitor Kappa B (IκB) Kinase 2 (IKK2) Activation Induces an Inflammatory State in Fibroblast-Like Synoviocytes [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/constitutive-inhibitor-kappa-b-i%ce%bab-kinase-2-ikk2-activation-induces-an-inflammatory-state-in-fibroblast-like-synoviocytes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/constitutive-inhibitor-kappa-b-i%ce%bab-kinase-2-ikk2-activation-induces-an-inflammatory-state-in-fibroblast-like-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology